Medikura is now XO Life!
XO Life (Medikura) Investment Exposé
Share your email address with us to receive investment information
€ 2 m
€ 9 m
1,0 % p.a. base interest + revenue share
Legal warning: The acquisition of this investment is associated with considerable risks and may lead to the complete loss of the invested assets. The promised return is not guaranteed and may also be lower.
The Trip Advisor for medicines with a scientifically validated data concept behind it.
XO Life is on its way to becoming the leading Real World Evidence (RWE) platform based on standardized patient reports in Germany and aims to capture millions of treatment data.
Recognized and honored
Unparalleled partner network, e.g. the leading national research institute for patient-centered research at Charité and publishers such as Wort & Bild (ApothekenUmschau) and other publishing houses.
XO Life has also been awarded several prizes and € 250,000 in funding on European level (EIC SME Instrument), German federal level (EXIST) and Bavarian state level.
Patients, medical staff und pharma
Together with its partners, XO Life is rolling out RWE’s leading platform for patient feedback across indications, offering:
- Patients & medical staff: better treatment monitoring and individualized treatment.
- Pharma: real insights into treatment satisfaction based on patient feedback; more cost-efficient & targeted R&D
What makes XO Life unique?
Reliable: Three years of platform operation in a highly sensitive environment, audited processes and compliance with legal guidelines.
Scalable: Real-world evidence database and platform technology as a hub for multiple applications and use cases.
Valuable: Establishment of a unique, pseudonymized database as the basis for precision medicine.
medwatcher.io is set to become the largest RWE platform, enabling patients to provide feedback on their care, compare themselves to other patients and receive updates about their treatment
Partnerships with major publishers
XO Life RWE database as a decision-making tool for life science companies, medical providers, insurers and other healthcare stakeholders
Partnership with world leader in health information technology
Digital treatment monitoring app
- Scalable, standardized and indication-independent web app for patient treatment monitoring
Partnerships with pharmaceutical companies and clinics
Digital patient engagement to increase adherence and improve customer loyalty
PV case management software
Software solution for pharmaceutical companies to facilitate safety case processing
Secure communication infrastructure between pharma and patients
Partnerships with medium-sized pharmaceutical companies
A Multidiciplinary Team
Entrepreneurs with excellent track records, accompanied by a scientific advisory board of leading European researchers.
Johannes is the brain behind XO Life – from Web Developer to Technical Lead. He has already gained a lot of valuable experience.
Dr. med. Maria Lutz
With Maria, XO Life has an excellent expert with years of experience in the medical field on board.
XO Life GmbH Contact & Legal notice
Notice under § 12 (2) & (3) of the German Investment Act (Vermögensanlagengesetz)
The acquisition of this investment is associated with considerable risks and may lead to the complete loss of the invested assets. The promised return is not guaranteed and may also be lower. aescuvest GmbH does not guarantee that reported interest will actually be achieved.
More information can be found under risk information.